Immunophenotypic Characterization of Crohn's Disease (CD) Responders to Vedolizumab
Latest Information Update: 25 Sep 2021
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Pharmacodynamics
- 08 Jun 2021 New trial record